Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.01 | 2.50%
Avg Daily Range (30 D):	$0.56 | 1.59%
Avg Daily Range (90 D):	$0.59 | 1.85%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	2,148
Avg Institutional Trade:	$1.7M
Avg Institutional Trade (30 D):	$1.44M
Avg Institutional Trade (90 D):	$1.42M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.43M
Avg Closing Trade (30 D):	$1.07M
Avg Closing Trade (90 D):	$1.07M
Avg Closing Volume:	34.45K

News

Sep 1, 2026 @ 11:00 AM Immunocore to present at upcoming investor confere... Source: Na

May 31, 2026 @ 12:00 PM Immunocore presents updated Phase 1 data of brenet... Source: Immunocore Holdings Plc

May 6, 2026 @ 11:00 AM Immunocore reports first quarter financial results... Source: Immunocore Holdings Plc

Apr 19, 2026 @ 10:00 PM KIMMTRAK doubles the likelihood of being alive at ... Source: Immunocore Holdings Plc

Mar 3, 2026 @ 12:00 PM Immunocore to present at upcoming investor confere... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.36	$-.02	$.26
Diluted EPS	$-.37	$-.02	$.25
Revenue	$430.78M	$115.93M	$106.68M
Gross Profit	$426.04M	$114.84M	$106.24M
Net Income / Loss	$-18.07M	$-.81M	$12.97M
Operating Income / Loss	$-22.58M	$-3M	$7.28M
Cost of Revenue	$4.74M	$1.09M	$.43M
Net Cash Flow	$-3.01M	$32.25M	$-15.03M
PE Ratio